Bohuslav Melichar

Olomouc, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 324 publications

Nivolumab in previously treated metastatic renal cell carcinoma: real-world data from the Czech Republic and Slovakia.

Nivolumab in previously treated metastatic renal cell carcinoma: real-world data from the Czech Republic and Slovakia.

Journal: Frontiers in immunology

Published: April 22, 2026

Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).

Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).

Journal: ESMO open

Published: April 21, 2026

Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumab.

Early systemic inflammatory-metabolic trajectory phenotypes are associated with survival outcomes in metastatic renal cell carcinoma treated with nivolumab.

Journal: Scientific reports

Published: March 10, 2026

Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group.

Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group.

Journal: Expert opinion on pharmacotherapy

Published: February 04, 2026

Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.

Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.

Journal: Gynecologic oncology

Published: February 02, 2026

A rare case of angiosarcoma of the ureter.

A rare case of angiosarcoma of the ureter.

Journal: Discover oncology

Published: January 20, 2026

Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses.

Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses.

Journal: Journal of gynecologic oncology

Published: January 19, 2026

The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab.

The Prognostic Role of Baseline and Early Dynamics of Peripheral Blood Cell Ratios in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab.

Journal: In vivo (Athens, Greece)

Published: November 04, 2025

Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.

Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.

Journal: JCO global oncology

Published: October 29, 2025

Challenging the dogma: why reviewers should be allowed to use AI tools.

Challenging the dogma: why reviewers should be allowed to use AI tools.

Journal: Clinical chemistry and laboratory medicine

Published: September 18, 2025

RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer.

RP-UHPLC/MS/MS provides enhanced lipidomic profiling of human serum in pancreatic cancer.

Journal: Analytica chimica acta

Published: September 15, 2025

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.

Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer.

Journal: Journal for immunotherapy of cancer

Published: August 22, 2025

Showing 1-12 of 324

Last Updated: 09/26/2026